Oxidative Stress

NRF2-Associated ROS Clearance by PRP-TPGN Hydrogel Accelerates Re-Epithelialization in Diabetic Wounds.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Abstract

In the diabetic wound microenvironment, excessive accumulation of reactive oxygen species (ROS) induces severe oxidative stress, thereby restricting re-epithelialization. Although platelet-rich plasma (PRP) gel can promote tissue repair by releasing platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), its bioactivity is substantially degraded by high ROS levels, which limits its clinical utility. To address this challenge, we designed a glucose-based molecular scaffold covalently conjugated with 4-Hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol) and phenylboronic acid pinacol ester (PBAP), designated TPG. This molecule spontaneously self-assembles into monodisperse spherical nanoparticles (TPG-PBAP-Glucose nanoparticles, TPGN), which exhibit favorable biocompatibility and H2O2-triggered degradation, enabling on-demand payload release within oxidative microenvironments. We further incorporated TPGN into PRP to form an in situ forming PRP-TPGN composite gel. In vitro functional assays demonstrated that this composite gel accelerated keratinocyte migration under high-glucose conditions by activating the nuclear factor erythroid 2-related factor 2 (NRF2) antioxidant signaling pathway; this protective effect was markedly attenuated by NRF2 knockdown or pharmacological inhibition. In streptozotocin-induced diabetic mice, PRP-TPGN expedited wound closure through NRF2-mediated ROS clearance, and this therapeutic benefit was largely diminished in NRF2-knockout animals. Collectively, the PRP-TPGN hydrogel constitutes a rationally designed, redox-synergistic therapeutic platform for the targeted management of refractory diabetic cutaneous ulcers.

Key Findings

  • The PRP-TPGN composite gel accelerates keratinocyte migration under high-glucose conditions by activating the NRF2 antioxidant signaling pathway.
  • The therapeutic effect of the PRP-TPGN gel is significantly reduced by NRF2 knockdown or pharmacological inhibition, indicating NRF2's critical role.
  • In diabetic mice, PRP-TPGN hydrogel expedites wound closure through NRF2-mediated ROS clearance, with diminished benefits observed in NRF2-knockout animals.

Clinical Significance

The PRP-TPGN hydrogel offers a novel redox-responsive therapeutic strategy to enhance diabetic wound healing by activating NRF2-dependent antioxidant defenses, addressing the challenge of oxidative stress in refractory diabetic ulcers.

Citation

Lin Jieru, Fan Yahan, Sun Rongwanet al.. NRF2-Associated ROS Clearance by PRP-TPGN Hydrogel Accelerates Re-Epithelialization in Diabetic Wounds. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2026-Nov-15.

DOI: 10.1002/advs.78799